Internal Medicine, Endocrinology, Diabetes, & Metabolism · New York, NY
NPI
1588729438
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
180 Fort Washington Ave
New York, NY, 10032
Phone (212) 305-3725
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,099
29 services
Medicare patients, 2024
19
Average age 73
Drug cost, 2024
$665K
183 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sharon L Wardlaw was code 99214 (office e&m - established), 13 times for 11 patients. In total Sharon L Wardlaw billed 29 services in 6 codes, and Medicare paid $2,099.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 13 | 11 | $103.97 | $1,352 |
By year: 2022 $2,048 for 25 services; 2023 $2,039 for 21 services; 2024 $2,099 for 29 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sharon L Wardlaw prescribed most often to Medicare patients was Levothyroxine Sodium, with 42 prescriptions and refills. In total Sharon L Wardlaw wrote 183 Medicare prescriptions that cost $665K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 42 | 95 | Under 11 | $699 |
| Hydrocortisone Generic | 34 | 36 | Under 11 | $697 |
| Prednisone Generic | 26 | 28 | Under 11 | $335 |
| Isturisa Osilodrostat Phosphate | 25 | 25 | Under 11 | $636K |
| Genotropin Somatropin | 14 | 14 | Under 11 | $23K |
Brand drugs: 62 claims; generic drugs: 121 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Sharon L Wardlaw were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.